Handelsbanken Fonder’s Caris Life Sciences CAI Stock Holding History

Handelsbanken Fonder’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$647K	Buy	+36,300	New	+$650K	﹤0.01%	1299

Other funds holding CAI

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Handelsbanken Fonder's CAI Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Caris Life Sciences (CAI) in Q2 2026: 36,300 shares worth $647K. The stake represents ﹤0.01% of the portfolio and ranks #1299 among its holdings.

44 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

Handelsbanken Fonder held 36,300 shares of Caris Life Sciences worth $647K as of Q2 2026.
Caris Life Sciences was a new Handelsbanken Fonder position in Q2 2026.
Caris Life Sciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1299 holding.
44 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.